The immunology of atherosclerosis.
Gisterå A, Hansson GK.
Nat Rev Nephrol. 2017 Jun;13(6):368-380. doi: 10.1038/nrneph.2017.51. Epub 2017 Apr 10.
When and How Should We Revascularize Patients With Atherosclerotic Renal Artery Stenosis?
Prince M, Tafur JD, White CJ.
JACC Cardiovasc Interv. 2019 Mar 25;12(6):505-517. doi: 10.1016/j.jcin.2018.10.023.
Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis.
Elfaki I, Mir R, Almutairi FM, Duhier FMA.
Asian Pac J Cancer Prev. 2018 Aug 24;19(8):2057-2070. doi: 10.22034/APJCP.2018.19.8.2057.
SOX4 is a novel phenotypic regulator of endothelial cells in atherosclerosis revealed by single-cell analysis.
Cheng CK, Lin X, Pu Y, Tse JKY, Wang Y, Zhang CL, Cao X, Lau CW, Huang J, He L, Luo JY, Shih YT, Wan S, Ng CF, Wang L, Ma RCW, Chiu JJ, Chan TF, Yu Tian X, Huang Y.
J Adv Res. 2023 Jan;43:187-203. doi: 10.1016/j.jare.2022.02.017. Epub 2022 Mar 1.
Relationship between renal volume and atherosclerosis in nondiabetic hypertensive patients with normal glomerular filtration rate.
Selvi E, Aybal Kutlugun A, Tangal NG, Murat K, Akkan T, Beyan E, Ramadan Uysal S.
Clin Exp Hypertens. 2021 May 19;43(4):373-377. doi: 10.1080/10641963.2021.1890765. Epub 2021 Feb 19.
Renal artery stenosis and accelerated atherosclerosis: which comes first?
Fava C, Minuz P, Patrignani P, Morganti A.
J Hypertens. 2006 Sep;24(9):1687-96. doi: 10.1097/01.hjh.0000242388.92225.2c.
Non-coronary atherosclerosis.
Gallino A, Aboyans V, Diehm C, Cosentino F, Stricker H, Falk E, Schouten O, Lekakis J, Amann-Vesti B, Siclari F, Poredos P, Novo S, Brodmann M, Schulte KL, Vlachopoulos C, De Caterina R, Libby P, Baumgartner I; European Society of Cardiology Working Group on Peripheral Circulation.
Eur Heart J. 2014 May;35(17):1112-9. doi: 10.1093/eurheartj/ehu071. Epub 2014 Mar 3.
Malnutrition-inflammation-atherosclerosis syndrome in patients with end-stage renal disease.
Zyga S, Christopoulou G, Malliarou M.
J Ren Care. 2011 Mar;37(1):12-5. doi: 10.1111/j.1755-6686.2011.00201.x.
Carbamylation-derived products: bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis.
Jaisson S, Pietrement C, Gillery P.
Clin Chem. 2011 Nov;57(11):1499-505. doi: 10.1373/clinchem.2011.163188. Epub 2011 Jul 18.
Targeting mitochondria-inflammation circle by renal denervation reduces atheroprone endothelial phenotypes and atherosclerosis.
Li Z, Li Q, Wang L, Li C, Xu M, Duan Y, Ma L, Li T, Chen Q, Wang Y, Wang Y, Feng J, Yin X, Wang X, Han J, Lu C.
Redox Biol. 2021 Nov;47:102156. doi: 10.1016/j.redox.2021.102156. Epub 2021 Sep 29.
